MEDICILON

contact us jpkrencn

事業内容

同所性腫瘍移植モデル

あなたはここにいる:ホーム > 事業内容 > 薬理薬効学の研究 > 同所性腫瘍移植モデル

Orthotopic cancer models by Medicilon were developed for use in the efficacy evaluation of novel anticancer compounds.

Orthotopic cancer models

Orthotopic cancer models by Medicilon were developed for use in the efficacy evaluation of novel anticancer compounds.


Cancer Type Cell Line Luciferase Cell Line
Breast carcinoma MDA-MB-231, HCC1954, HCC70, MDA-MB-361, MCF7, HCC1954,  MDA-MB-231-luc
Lung cancer NCI-H1650 A549-luc, LLC-luc
Colon carcinoma HCT-116
Glioblastoma U87-MG U87-MG-luc
Ovary carcinoma SK-OV-3
Prostate Cancer PC3
Leukemia RL, MAVER-1, Karpas299, K562, HL-60

Pharmacology Facility & Equipments

SPF Animal Room:
–Animal Storage: IVC System
–Combination of radiation and chemotherapy: RS 2000 Biological Research Irradiator
–In vivo tumor Imaging: IVIS Lumina III In Vivo Imaging System and Luciferase Cell Line

関連研究室